These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8657419)

  • 41. Is progestogen supplementation of ERT really necessary?
    Naftolin F; Silver D
    Menopause; 2002; 9(1):1-2. PubMed ID: 11791079
    [No Abstract]   [Full Text] [Related]  

  • 42. [Frequency of check-ups during post-climacteric hormonal treatment].
    Nordby K
    Tidsskr Nor Laegeforen; 1994 Jun; 114(15):1738-9. PubMed ID: 8079289
    [No Abstract]   [Full Text] [Related]  

  • 43. How should we give progestogen?
    Sturdee DW
    Climacteric; 2000 Sep; 3(3):153-4. PubMed ID: 11910615
    [No Abstract]   [Full Text] [Related]  

  • 44. Haematocervix during hormonal replacement therapy.
    Pansini F; Campobasso C; Bonaccorsi G; Calisesi M; Defazio DD; Perri G; Mollica G
    Eur J Obstet Gynecol Reprod Biol; 1993 Oct; 51(2):167-9. PubMed ID: 8119464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Efficacy of combined oral hormone replacement therapy in postmenopausal symptoms].
    Szántó F; Hörömpöli C
    Orv Hetil; 1996 May; 137(20):1079-81. PubMed ID: 8657419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lower doses of oral estrogen and progestogens as treatment for postmenopausal women.
    Archer DF
    Semin Reprod Med; 2005 May; 23(2):188-95. PubMed ID: 15852205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.